Joint Statement of the National Society of Genetic Counselors (NSGC), the American Society of Human Genetics (ASHG), the American College of Medical Genetics and Genomics (ACMG) - ASHG

Joint Statement of the National Society of Genetic Counselors (NSGC), the American Society of Human Genetics (ASHG), the American College of Medical Genetics and Genomics (ACMG)

ACMG Logo

ASHG Logo and Name in green

NSGC logo

Autism is a neurodevelopmental condition affecting approximately 1 in 31 children (3.2%) and approximately 2.2% of adults.[1],[2]

Research shows that genetic factors significantly contribute to autism; hundreds of genes and chromosomal variations are known to increase the likelihood of autism.[3]

Advances in genetic testing – such as genome sequencing – and large-scale collaborative genomic studies have improved the ability to identify likely genetic causes, which can allow early intervention for associated medical conditions to improve outcomes.[4],[5]


[1] Shaw, K. A., Williams, S., Patrick, M. E., et al. (2025). Prevalence and early identification of autism spectrum disorder among children aged 4 and 8 years — Autism and Developmental Disabilities Monitoring Network, 16 sites, United States, 2022. MMWR Surveillance Summaries, 74(SS-2), 1–22. https://doi.org/10.15585/mmwr.ss7402a1

[2] Dietz, P. M., Rose, C. E., McArthur, D., & Maenner, M. (2020). National and state estimates of adults with autism spectrum disorder. Journal of Autism and Developmental Disorders, 50(12), 4258–4266. https://doi.org/10.1007/s10803-020-04494-4

[3] Kim, S. W., & An, J. Y. (2025). Advancing precision diagnosis in autism: Insights from large-scale genomic studies. Molecules and cells, 48(8), 100248. https://doi.org/10.1016/j.mocell.2025.100248

[4] Specchio, N., Di Micco, V., Aronica, E., et al. (2025). The epilepsy-autism phenotype associated with developmental and epileptic encephalopathies: New mechanism-based therapeutic options. Epilepsia, 66(4), 970–987. https://doi.org/10.1111/epi.18209

[5] Stafford, C. F., & Sanchez-Lara, P. A. (2022). Impact of Genetic and Genomic Testing on the Clinical Management of Patients with Autism Spectrum Disorder. Genes, 13(4), 585. https://doi.org/10.3390/genes13040585